logo
From TB to HIV/AIDS to cancer, disease tracking has always had a political dimension, but it's the foundation of public health

From TB to HIV/AIDS to cancer, disease tracking has always had a political dimension, but it's the foundation of public health

Yahoo11-03-2025
Federal datasets began disappearing from public view on Jan. 31, 2025, in response to executive orders from President Donald Trump. Among those were the Centers for Disease Control and Prevention's Youth Risk Behavior Survey, which asks respondents about their gender identity and sexual orientation and tracks behaviors like smoking and drug use; CDC's HIV dataset; and CDC and Agency for Toxic Substances and Disease registry's Environmental Justice Index, which tracks pollution in communities, and Social Vulnerability Index, which identifies communities at high risk for disease and disability.
The collection of public health surveillance data has never been politically neutral. It has always reflected ideas about individual rights. With our colleagues James Colgrove and Daniel Wolfe, we have written about the history and ethics of surveillance. Despite controversy, it remains public health's foundational tool.
Surveillance typically involves tracking individuals with diseases by name for the purpose of direct action, including isolation, quarantine and treatment. It allows health officials to identify environmental threats and evaluate treatments. It allows governments to direct prevention and treatment resources where they are needed most, be that to a region or a group at highest risk. By the early 20th century, public health officials argued that without surveillance, they worked 'in the darkness of ignorance' and 'might as well hunt birds by shooting into every green bush.'
Three major controversies in the history of public health underscore what is at stake with the collection and maintenance of this information.
The collection of tuberculosis data provided the basic blueprint for public health surveillance.
Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the country to require that physicians report the names of TB patients in an effort to address the leading cause of death in both the city and the U.S.
The medical community bitterly resisted tuberculosis surveillance. A prominent New York City surgeon argued that surveillance represented a 'dictatorial … encroachment' of the health department that threatened to rob physicians of their patients.
But most people were not under the care of a private physician, and tuberculosis surveillance was a way to ensure that the largely immigrant poor living in the tenement districts got referrals to clinics, nourishment and, if necessary, isolation. Despite physicians' attempts to kill these efforts, there was no public outcry about tracking 'the great white plague' despite extensive, sensational coverage of the controversy in the popular press.
Debates around TB surveillance unfolded during a period in which both public health and medicine were highly paternalistic and authoritarian: Health department physicians or private physicians made medical decisions, not patients.
That changed with the AIDS epidemic, the first major infectious disease threat in more than a generation. AIDS arrived as American politics took a sharp conservative turn with the election of President Ronald Reagan. When in 1985 it became possible to test for HIV, the virus that causes AIDS, the prospect of named surveillance triggered deep fears about stigma and discrimination.
The prospect of reporting the names of those with HIV prompted one gay activist to declare, 'First comes the national registry, then come the boxcars, then come the camps for people with AIDS.' Gay rights advocates, who prioritized privacy, rejected HIV surveillance as a threat.
An alliance of gay rights leaders and civil liberties advocates was initially able to prevent health departments from undertaking named HIV surveillance. But by the end of the 1980s, there was growing pressure to return HIV/AIDS to 'the medical mainstream,' meaning that it could be managed therapeutically like other chronic conditions. As effective treatment became available in the 1990s, opposition faded, and all 50 states required named reporting.
If TB and HIV/AIDS reporting began as histories of resistance, the story was very different when it came to cancer reporting, which lagged far behind infectious disease surveillance.
In the wake of the environmental and women's movements, citizen activists, mothers of children with birth defects and women with breast cancer became alarmed about the threat of cancer linked to pesticides or industrial pollutants. Women with cancer asserted a 'right to be counted.' Although the National Cancer Act of 1971 directed the National Cancer Institute to 'collect, analyze, and disseminate all data useful in the prevention, diagnosis, and treatment of cancer,' by the 1980s, 10 states still had no registry.
Vermont's Bernie Sanders, then an independent member of the U.S. House of Representatives, called for a federally funded program to collect data on cancer in every state. Speaking in support of his bill in 1992, Sanders repeatedly invoked communities' right to know: 'We need to know the age of people who are coming down with cancer. We need to know where they live. We need to know the kind of work they do. We need their racial and ethnic backgrounds.'
President George H.W. Bush signed the Cancer Registries Amendment Act, which mandated cancer surveillance, into law in 1992. But it was not until 2000 that all states established cancer registries.
In the broader history of surveillance, two key lessons have emerged.
First, despite some pitched battles, communities have more often viewed surveillance as serving their interests.
Second, the system of public health surveillance in the U.S. remains an underfunded patchwork. The Pew Environmental Health Commission called birth defects surveillance 'woefully inadequate.' In 1972, the U.S. House Committee on Government Operations described occupational disease surveillance as '70 years behind infectious disease surveillance and counting.' In 2010, we ourselves observed that it was now 'a century behind and counting.'
The scope of the changes that the Trump administration has planned for federal data systems and datasets is unclear. Per a federal court order, key public health surveillance systems and datasets are back online. But the landing pages for both the Social Vulnerability Index and the Youth Risk Behavior Survey display a caveat based in politics rather than science that 'any information on this page promoting gender ideology is extremely inaccurate and disconnected from the immutable biological reality that there are two sexes, male and female.'
Systems can be compromised if datasets are scrubbed of key variables that enable public health action with populations at highest risk, are halted, or are removed from the public eye. Communities cannot act on what they cannot count.
This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Amy Lauren Fairchild, Syracuse University and Ronald Bayer, Columbia University Mailman School of Public Health
Read more:
COVID-19 is the latest epidemic to show biomedical breakthroughs aren't enough to eliminate a disease
Public health surveillance, from social media to sewage, spots disease outbreaks early to stop them fast
How to find climate data and science the Trump administration doesn't want you to see
Amy Lauren Fairchild has received funding from NIH and the RWJ Foundation. She currently receives funding from the Commonwealth Fund, the Mellon Foundation, and the National Science Foundation.
Ronald Bayer has received funding from the RWJ Foundation and NIH.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The 13 Foods That Could Save Your Kidneys and Your Wallet
The 13 Foods That Could Save Your Kidneys and Your Wallet

CNET

time11 minutes ago

  • CNET

The 13 Foods That Could Save Your Kidneys and Your Wallet

Your kidneys work quietly in the background every day, doing far more than most people realize. They filter waste from your blood, keep fluid levels balanced, help regulate hormones and play a role in everything from managing blood pressure to supporting healthy energy levels. Despite being so important, kidney health often does not get the attention it deserves. According to the CDC, more than 1 in 7 adults in the US are living with chronic kidney disease, and many are unaware they have it. That is why daily care and early prevention matter so much. Looking after your kidneys now can help them keep doing their job for years to come, and a few small, consistent habits can make a big difference. Don't miss any of CNET's unbiased tech content and lab-based reviews. Add us as a preferred Google source on Chrome. Fortunately, you don't need to make dramatic lifestyle changes to support kidney health. Incorporating a handful of nutrient-rich superfoods into your regular meals can make a significant difference. These foods help reduce inflammation, support healthy blood flow, and ease the load on your kidneys so they can keep doing their job. If you're looking to give your kidneys the boost they need, these 13 simple additions to your diet are a great way to start. Your diet and gut health also play a major role in your wellness, especially when it comes to keeping your kidneys healthy. There are 13 superfoods you should keep in mind when considering natural ways to give your kidney health a boost. Read more: 6 Important Blood Tests You May Need for Your Overall Health 13 superfoods for kidney health 1. Cabbage This nutrient-dense vegetable is low in both potassium and sodium while packing in fiber, vitamins C and K and more. Plus, cabbage is versatile. You can use it in salads and slaws, but you can also use it as a wrap for tacos, sandwiches and more. 2. Fatty fish Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids. Omega-3 fats may help reduce fat levels (triglycerides) in the blood and may also lower blood pressure, according to the National Kidney Foundation. If you have CKD, you may need to keep an eye on the phosphorus and potassium levels of the fish you choose. The National Kidney Foundation has a chart you can use to determine levels in specific types of fish. Although, it's best to consult with your doctor. Jacobs3. Bell peppers Like cabbage, bell peppers pack in lots of good nutrients with low levels of potassium. With them, you get vitamins B6, B9, C and K, plus fiber. They deliver antioxidants too. You can slice them and eat them with dips or roast them and add them to dinner. 4. Cranberries Cranberries help to prevent urinary tract infections. These usually stay in your bladder, they can travel up to your kidney, making kidney problems worse. Fortunately, regularly consuming cranberries can help you avoid this unwelcome situation. Plus, cranberries have antioxidants that can help fight inflammation, and they can boost your heart and digestive health. It turns out, these tart berries aren't just for the Thanksgiving table. 5. Blueberries We've talked about some of the best foods for kidneys, but you can take it a step further. The question is: What foods help repair kidneys? Blueberries deliver. With high levels of antioxidants and loads of vitamin C and fiber, blueberries are all-around healthy. They can also help to reduce inflammation and support bone health, reversing some of the issues that can come with CKD. 6. Dark, leafy greens There are plenty of reasons to turn to dark, leafy greens like spinach or kale. They deliver so many nutrients that they can help you get key vitamins and minerals, plus immunity-boosting benefits. Be advised that greens can come with a decent amount of potassium. If you have CKD, talk to your doctor before adding more of these to your diet. 7. Olive oil Rich in antioxidants and healthy fatty acids, olive oil can boost your overall wellness. A study from Harvard University found that olive oil may lower cholesterol levels and the risk of cardiovascular disease, dementia and some types of cancer. Beyond all this, it can help you add flavor to dishes without turning to salt or butter. To get more antioxidants, choose unrefined or cold-pressed olive oil that's virgin or extra virgin. 8. Garlic Another antioxidant-rich, inflammation-fighting food, garlic also contains a specific compound called allicin. For people with CKD, allicin — an active compound found in garlic — worked just as effectively to help protect kidney health as a prescription drug. If you're looking for the best foods for your kidneys, garlic has to make the list. Plus, it's an excellent way to add flavor when you're skimping on salt. 9. Onions From the same family as garlic, onions give you another excellent and salt-free way to add flavor (bonus points if you saute them in olive oil). Onions also deliver important nutrients like vitamins B6 and C, manganese and copper. They also contain quercetin, a chemical that can help your body fight cancer, and organic sulfur compounds that can reduce your risk of high blood pressure, stroke and heart disease. Getty Images 10. Cauliflower Cauliflower brings the crunch, paired with plenty of vitamins C, B6, B9 and K, along with fiber. It also contains compounds your body can use to neutralize certain toxins, a big help when your kidneys aren't doing their best filtration work. Cauliflower does contain some potassium and phosphorus, though, so while it makes the list of foods good for kidneys, people with CKD may want to moderate their intake. 11. Egg whites Egg whites are specifically recommended for people with kidney problems. They give you a way to increase your protein levels -- which can be important with later-stage CKD, especially if you're on dialysis. 12. Arugula Arugula is packed with nutrients your body needs like magnesium, iron, calcium and vitamins A, B9, C and K. Plus, it's antioxidant-rich and has glucosinolates, which can help your body protect itself against a range of cancer types. You can eat arugula raw (it's a great salad base), but you can also sprinkle it over whatever you're whipping up. It's great on pizzas, in omelets and with pasta, for example. 13. Apples Apples deliver the cancer-fighting quercetin and fiber that can help to keep your cholesterol and blood sugar at healthy levels. They've got plenty of antioxidants. Better yet, they're easy to work into your diet. Leave a bowl of apples on your counter and you'll have a kidney-healthy, grab-and-go snack whenever you need one.

Cutting mRNA Research Could Be Our Deadliest Mistake Yet
Cutting mRNA Research Could Be Our Deadliest Mistake Yet

Time​ Magazine

time12 minutes ago

  • Time​ Magazine

Cutting mRNA Research Could Be Our Deadliest Mistake Yet

The U.S. Department of Health and Human Services (HHS) recently announced it will wind down funding for mRNA vaccine development—which could prove to be one of the costliest, deadliest decisions HHS Secretary Robert F. Kennedy Jr. will make during his tenure. HHS has already scaled back access to and recommendations for COVID-19 vaccines—a decision experts are deeply concerned about—and Kennedy's frequently misinformed views on vaccines continue to fan the flames of anti-vaccination attitudes. Now, Kennedy's failure to fully explore the potential of mRNA vaccines could stagnate research that has the potential to save millions of lives around the world. The dark cloud of COVID-19, one of the deadliest infectious disease outbreaks in history, can hardly be thought of as having a silver lining. But the nearest thing to a glimmer of a positive would be that the fast development of COVID-19 vaccines helped prevent many more deaths and led to rapid progress in our understanding and use of mRNA technology. This greater understanding is now being explored as potential preventions or therapies for a wide range of diseases, from H5N1 bird flu and HIV to cancer. Terminating 22 mRNA projects will not only directly set back research on mRNA vaccines for infectious diseases including flu; it will also arguably have negative knock-on effects for researchers the world over exploring personalized treatments for noncommunicable diseases like cancer. Early research on some novel uses of mRNA is promising. For example, a preliminary trial of an mRNA HIV vaccine found that 80% of participants generated neutralizing antibodies, which in theory could help block HIV—pending further research and development. A melanoma mRNA vaccine, when combined with existing treatment, reduced the risk of death or disease recurrence by nearly 50%. (The vaccine is currently being tested further in a full scale Phase 3 clinical trial). Even more amazingly, personalized vaccines—where vaccines are created specifically for an individual using information from their cancer to optimize their immune response—using mRNA technology have even been proposed as a universal vaccine adaptable for all cancers. Read More: The CDC Shooting is a Dark Sign for Science and America Much of the research on personalized mRNA cancer vaccines is in some way indebted to gains in knowledge made from COVID-19 research, and it stands to reason that pulling such a large amount of funding from mRNA projects will slow down further progress in these areas. Approximately $500 million worth of research funding would almost certainly have advanced the scientific community's fundamental understanding of how, and to what extent, mRNA technology works and how it could be applied to prevent and fight disease. Also problematic is the manner in which HHS under Kennedy conveys their decisions. In announcing the funding withdrawal, HHS states it 'will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices.' This implies that mRNA vaccines have not been properly or transparently tested—which is not true. The safety of COVID-19 mRNA vaccines has been demonstrated in numerous studies and systematic evidence reviews. Like pretty much all vaccines and treatments, mRNA vaccines are not without side effects, but evidence shows that any adverse events are nearly always mild and short-lived. COVID-19 vaccines have already saved millions of lives globally, with mRNA vaccines accounting for a significant majority of all doses administered in many countries. Kennedy's claim that 'mRNA technology poses more risk than benefits' is almost farcical in light of scientific evidence. Moreover, the whole purpose of clinical research is to test whether new scientific innovations—like novel applications of mRNA into different diseases—are safe and effective in the first place. Kennedy has long spoken of how we need more evidence and testing on mRNA vaccines, and so it is painfully ironic that he is pulling funding for research which would enable the scientific community to do just that. Read More: An mRNA Melanoma Vaccine Shows Promise Perhaps most concerning is the caliber of evidence upon which decisions with such massive implications are being made. In an HHS announcement of the termination of mRNA projects, Kennedy claims 'the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.' The truth is, initial vaccines and booster doses have been shown to be very effective against reducing infection, hospitalization, and death from COVID-19. Kennedy does not even provide links or citations to systematic reviews or meta-analyses in reputable journals, the gold standard methods for scientific evidence. Rather, he simply links to an online evidence review which cherry picks studies searching only for the harms—and not the overall safety, effectiveness, or cost-benefit analysis—of the mRNA vaccines. The report does not describe the methods used to select and review studies, nor does it appear itself to have been peer-reviewed by other scientists. It almost certainly wouldn't be publishable in a scientific journal, yet it is being used as evidence to justify the fate of half a billion dollars of research funds. This is another example of how fringe viewpoints on mRNA technology, instead of the best available scientific evidence, are under Kennedy and HHS becoming the new mainstream. The U.S. has been at the forefront of developing mRNA technology for the past few decades, from the Nobel Prize-winning research of professors Katalin Kariko and Drew Weissman at the University of Pennsylvania on mRNA, to the key role of U.S.-based pharmaceutical companies in vaccine production and rollout. Perhaps other countries, companies, and funding sources will offset this funding loss and lead the development of mRNA vaccine innovations. Large investments are already being made in the U.K. and China, for example. That would be to the detriment of U.S. scientific innovation and progress. Kennedy is right to scrutinize the potential overreach of the pharmaceutical industry, and to ensure their research and development is ethical and transparent. However, his seemingly personal war against "Big Pharma" and ideological opposition to mRNA risks stunting research that could one day help prevent the next pandemic or even provide cures for hitherto incurable cancers.

AstraZeneca launches at-home FluMist nasal spray delivery

time42 minutes ago

AstraZeneca launches at-home FluMist nasal spray delivery

AstraZeneca is making flu protection more convenient with the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine, the company announced Friday. On the market since 2003, FluMist was previously only available at pharmacies or doctors' offices. Beginning Friday, eligible customers can order it online and have it shipped directly to their door, allowing parents to vaccinate their children at home without shots or a trip to the pharmacy. The spray can be self-administered by adults up to age 49, while caregivers can give it to children ages 2–17, the company said. The FDA approved FluMist for self- and caregiver-administration in September 2024, after research showed adults over 18 could safely and effectively administer it to eligible individuals. AstraZeneca hopes the needle-free option and at-home convenience will boost vaccination rates this year. Last year's flu season saw the highest number of flu-related deaths for children for a non-pandemic year -- 267 -- since the 2009 H1N1 pandemic, according to the Centers for Disease Control and Prevention. Health experts stress that vaccination remains the best protection against the virus, though getting kids vaccinated can be a challenge. The CDC continues to recommend that everyone 6 months and older get a flu vaccine this fall. Most health insurance plans are expected to cover the cost, with a shipping fee for four FluMist doses estimated at under $10. The company added for those who qualify, the nasal spray offers safety and effectiveness comparable to traditional flu shots.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store